Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases |
Myeloid Diseases | Phase1 | France Germany Hong Kong Italy Singapore Spain United Kingdom United States View All |
NCT05552469 |
Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease |
Steroid-refractory Acute Graft Versus Host Disease | Phase4 | China | NCT06462469 |
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor. |
Breast Cancer | Phase1, Phase2 | Australia Canada China France Germany Italy Netherlands Portugal Singapore South Korea Spain United Kingdom United States View All |
NCT06247995 |
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis |
Aortic Stenosis | Phase2 | Austria Belgium Canada Czechia Denmark France Germany Israel Italy Netherlands Portugal Spain Switzerland United Kingdom United States View All |
NCT05646381 |
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) |
Relapsing Multiple Sclerosis | Phase3 | Argentina Brazil Bulgaria Canada China Croatia Estonia France Greece India Italy Japan Mexico Poland Portugal Puerto Rico Romania Slovakia Slovenia South Africa Spain Sweden Turkey (Türkiye) United Kingdom United States View All |
NCT05156281 |
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan |
Prostate Cancer | Phase2 | Japan | NCT05114746 |
Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma |
Newly Diagnosed and Recurrent Glioblastoma | Phase1 | France Germany Israel Italy Portugal Spain United Kingdom United States View All |
NCT05739942 |
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer |
Metastatic Castration Resistant Prostate Cancer | Germany | NCT06517719 | |
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. |
C3G | Phase3 | Brazil Canada China France Germany Greece India Israel Italy Japan Netherlands Spain Switzerland Turkey (Türkiye) United Kingdom United States View All |
NCT04817618 |
Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world |
Breast Cancer | India | NCT05022342 |